• No results found

University of Groningen Towards prevention of AF progression Hobbelt, Anne

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Towards prevention of AF progression Hobbelt, Anne"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Towards prevention of AF progression

Hobbelt, Anne

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Hobbelt, A. (2019). Towards prevention of AF progression. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Towards prevention of AF

progression

(3)

Financial support for the publication of this thesis by the following companies/ institutes is gratefully acknowledged:

University of Groningen, Groningen University for Drug Exploration (GUIDE) The Dutch Heart Foundation

The research described in this thesis was supported by grants of the Dutch Heart Founda-tion (NHS2010B233, NHS2008B035, CVON 2014-09)

ISBN: 978-94-6361-231-9 © Copyright 2018 A.H. Hobbelt

All rights are reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means (electronic, mechanically, photocopy-ing, recording or otherwise), without the permission of the author, and when appropriate the publisher holding the copyrights of the published articles.

(4)

Towards prevention of AF progression Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op woensdag 24 april 2019 om 14.30 uur door

Anne Henrieke Hobbelt

geboren op 25 juni 1987 te Zwolle 3

Towards prevention of AF

progression

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op woensdag 24 april 2019 om 14.30 uur

door

Anne Henrieke Hobbelt

geboren op 25 juni 1987

(5)

Promotores

Prof. dr. I.C. van Gelder Prof. dr. M. Rienstra Prof. dr. H.J.G.M. Crijns

Beoordelingscommissie

Prof. dr. A.A. Voors Prof. dr. M.P. van den Berg Prof. dr. F.H. Rutten

(6)

Paranimfen

Lotte Gerjanne Hobbelt Mariëlle Kloosterman

(7)
(8)

Table of ConTenTs

Chapter 1: Introduction 9

Part I – New insights in the pathophysiologic mechanisms of atrial fibrillation Chapter 2: Prethrombotic state in young very-low-risk atrial fibrillation

patients

21 Published in Journal of the American College of Cardiology

Part II – Predictors of different atrial fibrillation patterns

Chapter 3: Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.

27

Published in Europace

Chapter 4: Progression of atrial fibrillation in a well-characterized low-risk AF population

43 In preparation

Part III – Clinical implications and future treatment strategies

Chapter 5: Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent AF - results of the RACE 3 trial

61

Published in European Heart Journal

Chapter 6: Editorial: The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy

81 Chapter 7: Tailored treatment strategies – a new approach for modern

management of atrial fibrillation

91 Published in Journal of Internal Medicine

Chapter 8: Discussion and future perspectives 109

Appendices: Nederlandse samenvatting 133

Dankwoord 139

Biography 143

(9)

Referenties

GERELATEERDE DOCUMENTEN

Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study. (epub ahead

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: valida- tion of the R(2)CHADS(2) index in the ROCKET AF

Stellingen behorende bij het proefschrift van Ernaldo Marcos met titel: Towards Improved Risk Prediction of Incident Atrial Fibrillation and. Progression of

Relevance of electrical remodeling in human atrial fibril- lation: Results of the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the

Therefore, our aim was to assess whether there are differences in coagulation activity between young very-low-risk patients with paroxysmal AF (age of onset <60 years) and

Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study..

An improved AF classification based on continuous rhythm monitoring and actual AF patterns, in addition to clinical characteristics may improve prediction of AF progression

The Routine versus Aggressive risk factor driven upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) trial was a prospective,